fda warning letters glp-1 compounding october 2025 is moving to restrict mass-marketed compounded products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Beyond the Headlines: FDA Warning
Description
Digestion: 10 Billion CFU of clinically studied probiotics
Collagen for Hair, Skin & Appearance: Includes 5g collagen peptides along with biotin, zinc, and vitamin C to support hair and skin health
and with patients who have taken GLP-1 drugs and experienced widely varying reactions.
GLP-1 receptor agonists represent a breakthrough for managing type-2 diabetes and obesity, offering metabolic benefits across multiple organ systems
